MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM

Glioblastoma is the most aggressive brain tumor in adults with a median survival below 12 months in population-based studies. The main reason for tumor recurrence and progression is constitutive or acquired resistance to the standard of care of surgical resection followed by radiotherapy with concom...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Stojcheva, Nina, Schechtmann, Gennadi, Sass, Steffen, Roth, Patrick, Florea, Ana-Maria, Stefanski, Anja, Stühler, Kai, Wolter, Marietta, Müller, Nikola S., Theis, Fabian J., Weller, Michael, Reifenberger, Guido, Happold, Caroline
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4914333/
https://ncbi.nlm.nih.gov/pubmed/26887050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7346
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados